On these pages you can check out the latest breast cancer news from BCAC and our member groups. We also provide up-to-date information and links to current breast cancer research and clinical trials. Read latest stories below, or use the filters or the pager below for other stories. Use the form to the right of this to subscribe to our e-News.
BCAC is speaking out in support of the thousands of New Zealanders with metastatic breast cancer today: Secondary Breast Cancer Awareness Day.
Secondary breast cancer is cancer that has spread from the breast to other parts of the body, such as the bones, brain or liver. It is incurable.
BCAC chairperson, Libby Burgess, says thousands of women in New Zealand are living with secondary breast cancer and they deserve special recognition and support.
The Pinc & Steel Cancer Rehabilitation Trust is delighted to be launching their PaddleOn Programme this summer in Auckland, Rotorua, Napier, Taupo and Orewa following the resounding success of the pilot programme.
A recent study has found concerns about fertility stop one third of young women with breast cancer from taking tamoxifen despite its known benefit in reducing the risk of breast cancer returning.
The study, which was published in the Journal of the National Cancer Institute also found one quarter of women who started taking tamoxifen stopped taking it before the recommended treatment period ended.
The Eliminate trial will investigate whether combining two breast cancer treatments before surgery is more effective than one treatment alone for women with large and complex ER+ breast cancer.
New research from two studies has found postmenopausal patients with early stage breast cancer who take two types of drugs, aromatase inhibitors (such as Letrozole or Anastrozole) together with bisphosphonates, have better survival rates than those who don’t.
Results from the two studies were collated by the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) group in the UK and published recently in The Lancet medical journal.
The latest innovation in fighting cancer has come to New Zealand and will be trialled in breast cancer patients from this month.
Immunotherapy, which is being used successfully to treat patients with melanoma, will now be trialled in patients with Triple Negative Breast Cancer (TNBC), a rare and aggressive form of breast cancer.
A Christchurch teacher is urging women to get regular mammograms after an aggressive breast cancer was picked up during her routine scan just prior to the February 2011 earthquake.
Hannelie Bergmann, 56, is speaking out in support of the Breast Cancer Aotearoa Coalition’s (BCAC) 2014 Show Your Heart for Women Living with Breast Cancer fundraising campaign.
An Auckland woman has considered selling her house to try and pay for the breast cancer medicine, Kadcyla, that will keep her alive. The same breast cancer medicine would be available free through the public health system if she lived in Australia.
“We have looked into selling and moving to the outer suburbs but it’s still very expensive. My husband is still working so we can’t leave Auckland,” says Jyoti (Jo) Bhagat.
The Breast Cancer Aotearoa Coalition (BCAC) welcomes news of the government’s new national cancer information strategy which is set to improve access to cancer information nationwide.